marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-13-2024
Adial Pharmaceuticals Financial Ratios 2011-2024 | ADIL
Annual Financial Ratios Adial Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.4 | -0.0 | -2.6 | -1.9 | -1.8 | -2.2 | - | - | - | - | - | - | - |
P/S |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EPS |
-3.6 | -12.7 | -1.0 | -0.9 | -0.9 | -2.4 | -0.3 | - | - | - | - | - | - |
EV (Enterprise Value) |
-128 K | -1.14 M | 48.1 M | 18.3 M | 9.43 M | 22.5 M | 1.01 M | 255 K | 53.1 K | - | - | - | - |
EBITDA per Share |
-4.14 | -10.2 | -1.04 | -1.11 | -0.837 | -1.47 | - | - | - | - | - | - | - |
EV/EBITDA |
-1.8 | -1.5 | -1.1 | -3.2 | - | - | - | - | - | - | - | ||
PEG |
- | 0.07 | -0.03 | 0.0 | - | - | - | - | - | - | - | ||
P/B |
0.5 | 0.1 | 14.3 | 5.3 | 2.2 | 5.9 | - | - | - | - | - | - | - |
P/CF |
-0.3 | -0.0 | -4.2 | -2.8 | -2.5 | -10.4 | - | - | - | - | - | - | - |
ROE % |
-125.46 | -388.57 | -553.72 | -273.28 | -120.32 | -261.89 | - | - | - | - | - | - | - |
ROA % |
-108.16 | -222.08 | -259.84 | -198.36 | -111.87 | -247.51 | - | - | - | - | - | - | - |
ROCE % |
-168.68 | -331.44 | -549.88 | -274.15 | -115.47 | -157.32 | - | - | - | - | - | - | - |
Current Ratio |
7.3 | 2.3 | 1.9 | 3.4 | 14.2 | 18.2 | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Adial Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.38 | -0.59 | - | -1.18 | 0.96 | -0.11 | - | -0.12 | -0.16 | -0.13 | - | -0.22 | -0.25 | -0.3 | - | -0.24 | -0.16 | -0.22 | - | -0.17 | -0.21 | -0.33 | - | -1.48 | -0.5 | -0.12 | - | -0.09 | -0.08 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | - | - | - | -0.11 | - | -0.12 | -0.16 | -0.13 | - | -0.2 | -0.25 | -0.3 | - | -0.24 | -0.16 | -0.22 | - | -0.17 | -0.21 | -0.27 | - | -0.69 | -0.49 | -0.1 | - | -0.08 | -0.07 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-213.14 | -143.10 | -228.23 | -285.71 | -283.99 | -365.11 | -132.97 | -192.94 | -195.42 | -239.06 | -237.98 | -321.67 | -345.38 | -298.86 | -186.24 | -210.27 | -150.62 | -135.07 | -91.49 | -275.92 | -436.31 | -446.78 | -233.31 | -119.09 | 179.56 | 334.14 | 228.45 | 228.45 | 114.23 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-178.93 | -117.49 | -93.99 | -134.15 | -126.02 | -190.03 | -96.21 | -137.54 | -138.71 | -158.57 | -152.45 | -213.20 | -232.61 | -210.51 | -135.19 | -157.53 | -119.13 | -113.94 | -85.07 | -259.37 | -411.33 | -421.68 | -220.51 | -3518.88 | -6642.95 | -9903.18 | -6596.75 | -6596.75 | -3298.37 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-207.17 | -214.12 | -305.44 | -364.37 | -365.25 | -368.83 | -135.61 | -192.05 | -189.56 | -232.64 | -233.79 | -317.54 | -344.86 | -299.29 | -187.09 | -211.53 | -152.23 | -136.84 | -86.18 | -172.11 | -233.58 | -242.56 | -132.78 | -106.47 | 5.76 | 69.18 | 50.51 | 50.51 | 24.21 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
8.1 | 7.4 | 7.2 | 5.4 | 8.2 | 1.6 | 2.3 | 3.3 | 3.7 | 4.3 | 1.9 | 3.2 | 2.5 | 2.9 | 3.6 | 3.6 | 3.6 | 3.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | 295.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | -295.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency